Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
5.93
-0.34 (-5.42%)
At close: Aug 1, 2025, 4:00 PM
5.94
+0.01 (0.17%)
After-hours: Aug 1, 2025, 7:56 PM EDT

Liminatus Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-3.55-3.55-4.98-2.93
Asset Writedown & Restructuring Costs
---0.9
Change in Accounts Payable
-0.01-0.010.430.09
Change in Other Net Operating Assets
2.112.111.211.07
Operating Cash Flow
-1.45-1.45-3.35-0.87
Investing Cash Flow
-2.85-2.85-0.82-
Short-Term Debt Issued
-3.923.419.44
Total Debt Issued
3.923.923.419.44
Short-Term Debt Repaid
---3.86-7.03
Total Debt Repaid
---3.86-7.03
Net Debt Issued (Repaid)
3.923.92-0.452.42
Issuance of Common Stock
---4.2
Repurchase of Common Stock
----0.7
Financing Cash Flow
3.923.92-0.455.92
Net Cash Flow
-0.38-0.38-4.615.05
Cash Interest Paid
---0.5
Levered Free Cash Flow
--2.92-2.3-
Unlevered Free Cash Flow
--2.71-2.19-
Change in Net Working Capital
-0.63-0.82-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.